These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27076282)

  • 1. Impact of an Institutional Change in Prothrombin Time Methodology on INR and MELD Scores in Liver Transplant Evaluations.
    Kumral D; Caldwell SH; Argo CK
    J Clin Lab Anal; 2016 Nov; 30(6):968-971. PubMed ID: 27076282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The international normalized ratio according to Owren in liver disease: interlaboratory assessment and determination of international sensitivity index.
    Magnusson M; Sten-Linder M; Bergquist A; Rajani R; Kechagias S; Fischler B; Németh A; Lindahl TL
    Thromb Res; 2013 Sep; 132(3):346-51. PubMed ID: 23993902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
    Tripodi A; Chantarangkul V; Primignani M; Fabris F; Dell'Era A; Sei C; Mannucci PM
    Hepatology; 2007 Aug; 46(2):520-7. PubMed ID: 17659574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
    Sermon AM; Smith JM; Maclean R; Kitchen S
    Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
    Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
    Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation.
    Li M; Zhang LP; Yang L
    Chin Med J (Engl); 2007 Nov; 120(22):1963-8. PubMed ID: 18067779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation.
    Trotter JF; Brimhall B; Arjal R; Phillips C
    Liver Transpl; 2004 Aug; 10(8):995-1000. PubMed ID: 15390325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure.
    Arjal R; Trotter JF
    Clin Liver Dis; 2009 Feb; 13(1):67-71. PubMed ID: 19150311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small difference in international normalized ratio may yield a significant impact on prioritizing patients listed for liver transplantation.
    Sarvary E; Seregely Z; Fazakas J; Kovacs F; Gaal I; Beko G; Varga J; Kobori L; Nemes B; Gorog D; Varga M; Langer RM; Monostory K; Jaray J; Gerlei Z
    Transplant Proc; 2010; 42(6):2317-22. PubMed ID: 20692471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplified method for international normalized ratio (INR) derivation based on the prothrombin time/INR line: an international study.
    Poller L; Ibrahim S; Keown M; Pattison A; Jespersen J
    Clin Chem; 2010 Oct; 56(10):1608-17. PubMed ID: 20798354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy.
    Heuman DM; Mihas AA; Habib A; Gilles HS; Stravitz RT; Sanyal AJ; Fisher RA
    Liver Transpl; 2007 Jan; 13(1):30-7. PubMed ID: 17154400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores.
    Jamil Z; Durrani AA
    Turk J Gastroenterol; 2018 May; 29(3):308-315. PubMed ID: 29755015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of INRs after local calibration of thromboplastin international sensitivity indexes.
    McGlasson DL
    Clin Lab Sci; 2002; 15(2):91-5. PubMed ID: 12776770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease.
    Lee JH; Kweon OJ; Lee MK; Lee HW; Kim HJ; Kim HR
    Int J Hematol; 2015 Aug; 102(2):163-9. PubMed ID: 26068391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score.
    Tripodi A; Chantarangkul V; Primignani M; Dell'Era A; Clerici M; Iannuzzi F; Aghemo A; Cazzaniga M; Salerno F; Mannucci PM
    J Hepatol; 2009 Aug; 51(2):288-95. PubMed ID: 19501423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory variability in assessment of the model of end-stage liver disease score.
    Lisman T; van Leeuwen Y; Adelmeijer J; Pereboom IT; Haagsma EB; van den Berg AP; Porte RJ
    Liver Int; 2008 Dec; 28(10):1344-51. PubMed ID: 18482269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simplified Method for Local Correction of System International Normalized Ratio.
    Chandrashekar V
    Lab Med; 2017 Aug; 48(3):244-248. PubMed ID: 28934513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.